References
- Barua NU, Lowis SP, Woolley M, et al. (2013a). Robot-guided convection-enhanced delivery of carboplatin for advanced brainstem glioma. Acta Neurochir (Wien) 155:1459–65
- Barua NU, Woolley M, Bienemann AS, et al. (2013b). Intermittent convection-enhanced delivery to the brain through a novel transcutaneous bone-anchored port. J Neurosci Methods 214:223–32
- Bienemann A, White E, Woolley M, et al. (2012). The development of an implantable catheter system for chronic or intermittent convection-enhanced delivery. J Neurosci Methods 203:284–91
- Bobo RH, Laske DW, Akbasak A, et al. (1994). Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA 91:2076–80
- Bogdahn U, Hau P, Stockhammer G, et al. (2011). Targeted therapy for high-grade glioma with the TGF-beta2 inhibitor trabedersen: results of a randomized and controlled phase IIb study. Neuro Oncol 13:132–42
- Bruce JN, Fine RL, Canoll P, et al. (2011). Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan. Neurosurgery 69:1272–9
- Castello MA, Clerico A, Deb G, et al. (1990). High-dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors. Am J Pediatr Hematol Oncol 12:297–300
- Chinot OL, De La Motte Rouge T, Moore N, et al. (2011). AVAglio: phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme. Adv Ther 28:334–40
- Cloughesy TF, Gobin YP, Black KL, et al. (1997). Intra-arterial carboplatin chemotherapy for brain tumors: a dose escalation study based on cerebral blood flow. J Neurooncol 35:121–31
- Dun CA, Faber HT, De Wolf MJ, et al. (2011). An overview of different systems: the bone-anchored hearing aid. Adv Otorhinolaryngol 71:22–31
- Follezou JY, Fauchon F, Chiras J. (1989). Intraarterial infusion of carboplatin in the treatment of malignant gliomas: a phase II study. Neoplasma 36:349–52
- Iyer RR, Butman JA, Walbridge S, et al. (2011). Tracking accuracy of T2- and diffusion-weighted magnetic resonance imaging for infusate distribution by convection-enhanced delivery. J Neurosurg 115:474–80
- Larner JM, Phillips CD, Dion JE, et al. (1995). A phase 1-2 trial of superselective carboplatin, low-dose infusional 5-fluorouracil and concurrent radiation for high-grade gliomas. Am J Clin Oncol 18:1–7
- Leuraud P, Taillandier L, Medioni J, et al. (2004). Distinct responses of xenografted gliomas to different alkylating agents are related to histology and genetic alterations. Cancer Res 64:4648–53
- Mueller S, Polley MY, Lee B, et al. (2011). Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study. J Neurooncol 101:267–77
- Qureshi AI, Suri MF, Khan J, et al. (2001). Superselective intra-arterial carboplatin for treatment of intracranial neoplasms: experience in 100 procedures. J Neurooncol 51:151–8
- Sampson JH, Archer G, Pedain C, et al. (2010). Poor drug distribution as a possible explanation for the results of the PRECISE trial. J Neurosurg 113:301–9
- Sampson JH, Raghavan R, Provenzale JM, et al. (2007). Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin. AJR Am J Roentgenol 188:703–9
- Silvani A, Eoli M, Salmaggi A, et al. (2002). Intra-arterial ACNU and carboplatin versus intravenous chemotherapy with cisplatin and BCNU in newly diagnosed patients with glioblastoma. Neurol Sci 23:219–24
- Stalfors J, Tjellstrom A. (2008). Skin reactions after BAHA surgery: a comparison between the U-graft technique and the BAHA dermatome. Otol Neurotol 29:1109–14
- Stewart DJ, Belanger JM, Grahovac Z, et al. (1992). Phase I study of intracarotid administration of carboplatin. Neurosurgery 30:512–6; discussion 516–7
- Stupp R, Mason WP, Van den Bent MJ, et al. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–96
- White E, Bienemann A, Pugh J, et al. (2012a). An evaluation of the safety and feasibility of convection-enhanced delivery of carboplatin into the white matter as a potential treatment for high-grade glioma. J Neurooncol 108:77–88
- White E, Bienemann A, Taylor H, et al. (2012b). A phase I trial of carboplatin administered by convection-enhanced delivery to patients with recurrent/progressive glioblastoma multiforme. Contemp Clin Trials 33:320–31
- Whittle IR, Malcolm G, Jodrell DI, Reid M. (1999). Platinum distribution in malignant glioma following intraoperative intravenous infusion of carboplatin. Br J Neurosurg 13:132–7
- Wolff JE, Trilling T, Molenkamp G, et al. (1999). Chemosensitivity of glioma cells in vitro: a meta analysis. J Cancer Res Clin Oncol 125:481–6
- Yang W, Huo T, Barth RF, et al. (2011). Convection enhanced delivery of carboplatin in combination with radiotherapy for the treatment of brain tumors. J Neurooncol 101:379–90